Literature DB >> 17638670

Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.

Dominick Amato1, David G Oscier, Zadie Davis, Sarah Mould, Jianing Zheng, Elena Kolomietz, Chen Wang.   

Abstract

The finding of monoclonal B-cell lymphocytosis (MBL) raises questions on the nature of clonal cell expansion and its risk of progression. We identified and characterized 7 cases of clinically benign clonal B-cell lymphocytosis. The clonal lymphocytes were clearly of CD5- and non-chronic lymphocytic leukemia (CLL) phenotype. All cases had mild to moderate absolute lymphocytosis. The clonal population accounted for 95% to 99% of B cells. For a follow-up period of 4 to 16 years, clonal lymphocytosis was persistent but virtually not progressing. Patients' conditions remained clinically stable and asymptomatic. The clonal populations had somatic hypermutations of the VH gene in 6 cases, indicating a germinal center or post-germinal center B-lymphocyte origin. Clonal cytogenetic aberrations were found in 5 of 6 cases, with 2 clones bearing isochromosome 17q that resulted in loss of p53 and 2 other clones with 7q abnormalities. By the presence of absolute lymphocytosis, this series differs from MBL cases identified by sensitive flow cytometry in normal populations. The phenotypic profiles are distinct from that of benign CLL. We suggest these CD5-B-cell lymphocytosis cases may represent an intermediate condition between covert clonal expansions and overt malignancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638670     DOI: 10.1309/WB56ET6AGM44TM5T

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

Review 2.  Monoclonal B cell lymphocytosis: clinical and population perspectives.

Authors:  Neil E Caporaso; Gerald E Marti; Ola Landgren; Elizabeth Azzato; J Brice Weinberg; Lynn Goldin; Tait Shanafelt
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

Review 3.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

Review 4.  New insights into monoclonal B-cell lymphocytosis.

Authors:  Christina Kalpadakis; Gerassimos A Pangalis; Sotirios Sachanas; Theodoros P Vassilakopoulos; Stavroula Kyriakaki; Penelope Korkolopoulou; Efstathios Koulieris; Maria Moschogiannis; Xanthi Yiakoumis; Pantelis Tsirkinidis; Marie-Christine Kyrtsonis; Georgia Levidou; Helen A Papadaki; Panayiotis Panayiotidis; Maria K Angelopoulou
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

5.  Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis.

Authors:  I V Kostopoulos; G Paterakis; D Pavlidis; E Kastritis; E Terpos; O E Tsitsilonis; S I Papadhimitriou
Journal:  Blood Cancer J       Date:  2017-08-25       Impact factor: 11.037

6.  Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis.

Authors:  In Young Yoo; Sung Hoan Bang; Dae Jin Lim; Seok Jin Kim; Kyunga Kim; Hee Jin Kim; Sun-Hee Kim; Duck Cho
Journal:  Ann Lab Med       Date:  2020-09       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.